Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...
Severe acute pancreatitis is frequently complicated by hospital-acquired infections that worsen outcomes and prolong intensive care stays. New evidence suggests that modulating the microbiome may ...
A recent Nature article on novel GLP-1 therapies underscores a truth few key opinion leaders in medicine like to focus on: Even the most clinically impactful pharmaceutical accomplishments carry ...
Pancreas with pancreatitis in human body The inappropriate use of antibiotics as prophylaxis and treatment in acute pancreatitis is common, highlighting the efforts required for antibiotic stewardship ...
Ionis Pharma projects $2B+ peak revenue for Olezarsen, which is highly conservative given the U.S. addressable market. Read ...
The current study analyzed data from 10 Korean hospital databases and included a total of 5644 patients with AP. Patients with high triglycerides had significantly higher levels of C-reactive protein ...
Over one third of patients with acute pancreatitis develop exocrine pancreatic insufficiency (EPI) at 12 months, with the key predictors being idiopathic etiology, moderately severe or severe disease, ...
Please provide your email address to receive an email when new articles are posted on . Adding olezarsen to lipid-lowering therapy significantly reduced triglyceride levels at 6 months vs. placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results